Siegel will assume responsibility for all manufacturing operations, including supply chain management and product distribution services, for the Solexa Genome Analysis System and related consumables
Solexa has announced the appointment of Brock Siegel to the newly created position of chief operating officer.
"Brock's extensive experience directing a wide range of global operations, product engineering and quality-related processes is well suited for this key position," said John West, chief executive officer of Solexa.
"He has facilitated production of over 3000 products and has achieved an impressive track record in implementing operational efficiencies.
"His timely addition to the company will significantly enhance our ability to put in place manufacturing infrastructure and processes necessary to respond to the expected demand for the Solexa Genome Analysis System at broad commercial release".
Siegel, 58, has 26 years of global industry experience, including the last 15 years with Applied Biosystems in a variety of senior management positions involving product development and manufacturing of devices and consumables.
He served most recently as vice president, quality and process excellence.
Prior to his tenure with Applied Biosystems, Dr Siegel managed manufacturing, commercialization and research and development of DNA/protein consumables for scientific and technical instruments at Millipore.
He also held positions of increasing responsibility in product and process development and chemical engineering at Henkel Research and its parent, Henkel in Dusseldorf, Germany.
"With its commercial systems already at multiple leading institutes, Solexa is successfully executing on its plans to deliver this transforming technology to researchers in 2006," said Siegel.
"I am delighted to join this leading organization at such an exciting time, and I look forward to contributing to the ongoing commercial success of the company".
Siegel served as professor of bio-organic chemistry and chemical engineering at the University of Minnesota and conducted post-doctoral work on enzyme mechanisms and organic model systems at Columbia University.
He received a PhD from the University of Illinois, where he focused on analytical instrumentation, and a BS in chemistry from Syracuse University.
